BIOMAT Database Logo BIOMAT Database Logo

Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra. 1978

A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni

UI MeSH Term Description Entries
D008297 Male Males
D008735 5-Methoxytryptamine Serotonin derivative proposed as potentiator for hypnotics and sedatives. Meksamine,Methoxytryptamine,Mexamine,5 Methoxytryptamine
D009433 Neural Inhibition The function of opposing or restraining the excitation of neurons or their target excitable cells. Inhibition, Neural
D009434 Neural Pathways Neural tracts connecting one part of the nervous system with another. Neural Interconnections,Interconnection, Neural,Interconnections, Neural,Neural Interconnection,Neural Pathway,Pathway, Neural,Pathways, Neural
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni
Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
January 1978, Advances in biochemical psychopharmacology,
A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni
Apomorphine-induced alterations in striatal and substantia nigra pars reticulata glutamate following unilateral loss of striatal dopamine.
May 2005, Experimental neurology,
A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni
Dopamine release in substantia nigra?
March 1976, Nature,
A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni
Indirect presynaptic modulation of striatal dopamine release by GABA(B) receptors in the rat substantia nigra.
May 2002, Neuroscience letters,
A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni
Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
July 1995, Journal of neurochemistry,
A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni
Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
January 1998, Advances in pharmacology (San Diego, Calif.),
A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni
Inhibition by aripiprazole of dopaminergic inputs to striatal neurons from substantia nigra.
September 1999, Psychopharmacology,
A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni
Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
January 2010, Experimental neurology,
A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni
Apomorphine-induced inhibition of substantia nigra dopamine neurons: effects of unilateral injection through the internal carotid artery.
March 1989, Neuroscience letters,
A Maggi, and F Bruno, and F Cattabeni, and A Groppetti, and M Parenti, and G Racagni
Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.
November 2014, Journal of neurochemistry,
Copied contents to your clipboard!